EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review

Kevin Y Wu iD, Hamza Ahmad, Grace Lin, Marjorie Carbonneau, Simon D Tran iD

Pharmaceutics · 06.04.2023 · 15 (4) · 1167

DOI: 10.3390/pharmaceutics15041167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 06.04.2023. Verfasst von Kevin Y Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery-Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, the field of mesenchymal stem cell (MSC) therapy has exhibited rapid growth. Due to their regenerative, reparatory, and immunomodulatory capacities, MSCs have been widely investigated as therapeutic agents in the cell-based treatment of chronic ophthalmic pathologies. However, the applicability of MSC-based therapy is limited by suboptimal biocompatibility, penetration, and delivery to the target ocular tissues. An emerging body of research has elucidated the role of exosomes in the biological functions of MSCs, and that MSC-derived extracellular vesicles (EVs) possess anti-inflammatory, anti-apoptotic, tissue repairing, neuroprotective, and immunomodulatory properties similar to MSCs. The recent advances in MSCs-derived exosomes can serve as solutions to the challenges faced by MSCs-therapy. Due to their nano-dimensions, MSC-derived exosomes can rapidly penetrate biological barriers and reach immune-privileged organs, allowing for efficient delivery of therapeutic factors such as trophic and immunomodulatory agents to ocular tissues that are typically challenging to target by conventional therapy and MSCs transplantation. In addition, the use of EVs minimizes the risks associated with mesenchymal stem cell transplantation. In this literature review, we focus on the studies published between 2017 and 2022, highlighting the characteristics of EVs derived from MSCs and their biological functions in treating anterior and posterior segment ocular diseases. Additionally, we discuss the potential use of EVs in clinical settings. Rapid advancements in regenerative medicine and exosome-based drug delivery, in conjunction with an increased understanding of ocular pathology and pharmacology, hold great promise for the treatment of ocular diseases. The potential of exosome-based therapies is exciting and can revolutionize the way we approach these ocular conditions.

Schlagwörter

Stichwörter der Autor:innen

MSC-derived exosomeMSCs-based cell therapyanterior segment diseasescell-based drug delivery systemsexosomes-based drug deliveryocular pharmacologyophthalmologyposterior segment diseasestissue repair and regeneration

Autor:innen und Institutionen

  • Department of Surgery-Division of Ophthalmology, University of Sherbrooke, Sherbrooke, QC J1G 2E8, Canada.
  • Faculty of Medicine, McGill University, Montreal, QC H3A 0G4, Canada.
  • Faculty of Medicine, University of Montreal, Montreal, QC H3T 1J4, Canada.
  • Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC H3A 1G1, Canada.

ORCID-Profile: Kevin Y Wu, Simon D Tran

Zitieren

APA

Wu, K. Y., Ahmad, H., Lin, G., Carbonneau, M., & Tran, S. D. (2023). Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review. Pharmaceutics, 15(4), 1167. https://doi.org/10.3390/pharmaceutics15041167

Vancouver

Wu KY, Ahmad H, Lin G, Carbonneau M, Tran SD. Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review. Pharmaceutics. 2023;15(4):1167. doi:10.3390/pharmaceutics15041167

BibTeX
@article{Wu2023,
  author = {Wu, Kevin Y and Ahmad, Hamza and Lin, Grace and Carbonneau, Marjorie and Tran, Simon D},
  title = {Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1167},
  doi = {10.3390/pharmaceutics15041167}
}
Kostenlos starten →